CLEARBRIDGE ENERGY MIDSTREAM (EMO) Fundamental Analysis & Valuation

NYSE:EMO • US18469P2092

Current stock price

48.44 USD
-0.72 (-1.46%)
Last:

This EMO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. EMO Profitability Analysis

1.1 Basic Checks

  • In the past year EMO was profitable.
  • In the past year EMO had a positive cash flow from operations.
  • EMO had positive earnings in 4 of the past 5 years.
  • In multiple years EMO reported negative operating cash flow during the last 5 years.
EMO Yearly Net Income VS EBIT VS OCF VS FCFEMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

Industry RankSector Rank
ROA 10.43%
ROE 14.6%
ROIC N/A
ROA(3y)17.21%
ROA(5y)-5.19%
ROE(3y)24.56%
ROE(5y)-6.89%
ROIC(3y)N/A
ROIC(5y)N/A
EMO Yearly ROA, ROE, ROICEMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

  • In the last couple of years the Profit Margin of EMO has declined.
  • EMO does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 603.29%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.55%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EMO Yearly Profit, Operating, Gross MarginsEMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K -4K -6K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. EMO Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for EMO has been increased compared to 1 year ago.
  • Compared to 5 years ago, EMO has more shares outstanding
  • The debt/assets ratio for EMO has been reduced compared to a year ago.
EMO Yearly Shares OutstandingEMO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
EMO Yearly Total Debt VS Total AssetsEMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

  • Based on the Altman-Z score of 1.61, we must say that EMO is in the distress zone and has some risk of bankruptcy.
  • EMO has a debt to FCF ratio of 0.98. This is a very positive value and a sign of high solvency as it would only need 0.98 years to pay back of all of its debts.
  • A Debt/Equity ratio of 0.33 indicates that EMO is not too dependend on debt financing.
  • Although EMO's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 0.98
Altman-Z 1.61
ROIC/WACCN/A
WACCN/A
EMO Yearly LT Debt VS Equity VS FCFEMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.16 indicates that EMO should not have too much problems paying its short term obligations.
  • A Quick Ratio of 1.16 indicates that EMO should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
EMO Yearly Current Assets VS Current LiabilitesEMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. EMO Growth Analysis

3.1 Past

  • EMO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -68.40%.
  • EMO shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.54% yearly.
  • EMO shows a strong growth in Revenue. In the last year, the Revenue has grown by 67.73%.
  • EMO shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.84% yearly.
EPS 1Y (TTM)-68.4%
EPS 3Y12.54%
EPS 5YN/A
EPS Q2Q%-156.87%
Revenue 1Y (TTM)67.73%
Revenue growth 3Y43.68%
Revenue growth 5Y2.84%
Sales Q2Q%131.79%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EMO Yearly Revenue VS EstimatesEMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M

More info and screens

Find the best growth stocksShow best growing peers

1

4. EMO Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 10.33, the valuation of EMO can be described as very reasonable.
  • EMO is valuated cheaply when we compare the Price/Earnings ratio to 27.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.33
Fwd PE N/A
EMO Price Earnings VS Forward Price EarningsEMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 3.19
EV/EBITDA N/A
EMO Per share dataEMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. EMO Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 8.58%, EMO is a good candidate for dividend investing.
  • Compared to an average S&P500 Dividend Yield of 1.82, EMO pays a better dividend.
Industry RankSector Rank
Dividend Yield 8.58%

5.2 History

  • The dividend of EMO decreases each year by -14.22%.
  • EMO has been paying a dividend for at least 10 years, so it has a reliable track record.
  • EMO has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-14.22%
Div Incr Years4
Div Non Decr Years4
EMO Yearly Dividends per shareEMO Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10 20 30

5.3 Sustainability

  • EMO pays out 40.15% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP40.15%
EPS Next 2YN/A
EPS Next 3YN/A
EMO Yearly Income VS Free CF VS DividendEMO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
EMO Dividend Payout.EMO Dividend Payout, showing the Payout Ratio.EMO Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

EMO Fundamentals: All Metrics, Ratios and Statistics

CLEARBRIDGE ENERGY MIDSTREAM

NYSE:EMO (4/17/2026, 8:08:24 PM)

48.44

-0.72 (-1.46%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)02-03
Earnings (Next)07-28
Inst Owners27.58%
Inst Owner Change16.53%
Ins Owners0%
Ins Owner Change1.38%
Market Cap969.28M
Revenue(TTM)21.88M
Net Income(TTM)132.00M
Analysts0
Price TargetN/A
Short Float %0.09%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield 8.58%
Yearly Dividend2.14
Dividend Growth(5Y)-14.22%
DP40.15%
Div Incr Years4
Div Non Decr Years4
Ex-Date05-21
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.33
Fwd PE N/A
P/S 44.3
P/FCF 3.19
P/OCF 3.19
P/B 1.07
P/tB 1.07
EV/EBITDA N/A
EPS(TTM)4.69
EY9.68%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)15.19
FCFY31.36%
OCF(TTM)15.19
OCFY31.36%
SpS1.09
BVpS45.18
TBVpS45.18
PEG (NY)N/A
PEG (5Y)N/A
Graham Number69.046 (42.54%)
Profitability
Industry RankSector Rank
ROA 10.43%
ROE 14.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 603.29%
GM N/A
FCFM 1389.4%
ROA(3y)17.21%
ROA(5y)-5.19%
ROE(3y)24.56%
ROE(5y)-6.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.55%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 0.98
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 230.3%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.61
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.4%
EPS 3Y12.54%
EPS 5YN/A
EPS Q2Q%-156.87%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)67.73%
Revenue growth 3Y43.68%
Revenue growth 5Y2.84%
Sales Q2Q%131.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y877.49%
FCF growth 3YN/A
FCF growth 5Y26.17%
OCF growth 1Y877.49%
OCF growth 3YN/A
OCF growth 5Y26.17%

CLEARBRIDGE ENERGY MIDSTREAM / EMO Fundamental Analysis FAQ

What is the fundamental rating for EMO stock?

ChartMill assigns a fundamental rating of 2 / 10 to EMO.


What is the valuation status of CLEARBRIDGE ENERGY MIDSTREAM (EMO) stock?

ChartMill assigns a valuation rating of 1 / 10 to CLEARBRIDGE ENERGY MIDSTREAM (EMO). This can be considered as Overvalued.


Can you provide the profitability details for CLEARBRIDGE ENERGY MIDSTREAM?

CLEARBRIDGE ENERGY MIDSTREAM (EMO) has a profitability rating of 1 / 10.


Is the dividend of CLEARBRIDGE ENERGY MIDSTREAM sustainable?

The dividend rating of CLEARBRIDGE ENERGY MIDSTREAM (EMO) is 5 / 10 and the dividend payout ratio is 40.15%.